AI assistant
RESMED INC — Director's Dealing 2021
Nov 18, 2021
30071_dirs_2021-11-18_dec71496-8f9f-46d6-9ed9-06bf9da98d7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-16
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-16 | ResMed Common Stock | A | 45811 | $254.81 | Acquired | 67077 | Direct |
| 2021-11-17 | ResMed Common Stock | F | 27135 | $254.81 | Disposed | 39942 | Direct |
| 2021-11-18 | ResMed Common Stock | A | 2612 | — | Acquired | 42554 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 210407 | Indirect |
Footnotes
F1: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.
F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.
F3: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.